On the Road to Provider Status
Billing solutions and entrepreneurs needed.
Five Tips for Evaluating Clinical Studies
Be an expert at evaluating clinical studies with some simple tools.
Hospital Drug Diversion: An Underreported Threat
Results of a recent survey suggest employee-based drug abuse is a concern for many healthcare providers, though they don’t believe it can happen in their facilities.
COTA Signs Agreement with FDA for Breast Cancer Research
The agreement will bring real-world data to cancer treatment development.
ASHP and ASPEN Launch Professional Nutritional Support Certificate
Earn up to 19.25 hours of CE.
New Gene Therapy for Pediatric Spinal Muscular Atrophy Approved by FDA
Zolgensma (onasemnogene abeparvovec-xioi) is an adeno-associated virus vector-based gene therapy
A Closer Look at Sunscreens
Deciding which sunscreen to apply has become a complicated business.
Proposed North Carolina Bill Could Increase Pharmacists' Immunizing Abilities
North Carolina working to expand the number of vaccines pharmacists can administer.
Scientists Are One Step Closer to Needleless Hepatitis B Vaccine
Medical researchers and physicists are collaborating on oral vaccine research.
Study Finds a Lack of Deprescribing is Harmful and Expensive
Studies indicate a lack of deprescribing is causing physical and fiscal pain to patients.
CBD Products: Confusion, Hype, and Hope
Despite legal restrictions and insufficient regulation, the market for CBD oil is booming.
Gilead Makes Years-Long Donation of Truvada to the CDC
The company is donating enough drugs for 200,000 patients for up to 11 years, but does it make up for the high price of the drug?
HHS Now Requiring Manufacturers to Disclose Drug Prices in TV Ads
Finalized rule is a step toward increasing drug pricing transparency.
CDC Responds to Instances of Misapplication of Opioid Guidelines
Physicians have been misapplying the CDC’s 2016 opioid prescribing guideline, causing challenges for some pain patients, according to a new commentary.
EPA’s New Rules on Drug Disposal Begin in August
Approved regulations allow for some flexibility for drugs that can be redistributed or qualify for manufacturer credit.
Pharmacists Must Counsel on Cannabis Interactions
Lack of regulation means protecting public health is pharmacist's duty.
Clinical Pharmacists Are Integral Team Members in PCMHs
Soltamox (Tamoxifen Citrate) Issued Labeling Change
Women no longer require nine months of contraception post cessation of the drug.
Harnessing Technology to Enhance Diabetes Adherence
Increase adherence by matching technology to each patient's unique needs.
DOVATO (Dolutegravir and Lamivudine) Approved for HIV-1
First-ever dual-drug, single tablet for HIV offers lighter treatment regimen.
FDA Warns on Use of Pre-Owned or Unauthorized Test Strips
Consumers are using test strips that might lead to inaccurate results.
Breast Cancer Drug Gains Approval for Males
America's Polypharmacy Predicament
New report highlights the dangers of prescription medications beyond opioids.
Hypertension Control Program May Go Nationwide
The program increased hypertension management rates to 77% in 2017.
Acid Reflux Drugs Linked to Kidney Disease Risk
Patients taking PPIs 28.4 times more likely to develop chronic kidney disease.
New Research Aims to Combat Flu Pandemics
Researchers targeting virus' receptors used to enter the body.
Zulresso Approved for Postpartum Depression in Adult Women
First drug approved for PPD use to remain under REMS program.
Patients with Cognitive Impairment Less Likely to Get OACs
Study finds different anticoagulation treatment levels for patients with cognitive problems.
Serious Shingrix Side Effects Are Rare
Safety monitoring findings for Shingrix are consistent with clinical trial data.
Women at Greater Risk of Developing Shingles
Pregnancy and menopause are contributing factors.
